Regulus Therapeutics

Regulus Therapeutics Inc. is a clinical stage biopharmaceutical company focused on the development of first-in-class drugs that target microRNAs to treat a broad range of diseases. Regulus was established... Wikipedia

• Type:  Public
• Traded as:  NASDAQ: RGLS
• Industry:  Biotechnology
• Key people:  Jay Hagan (president and CEO), Cris Calsada (CFO)
• Products:  microRNA therapeutics
• Number of employees:  30
• Data source:  DuckDuckGo